Dazed and confused [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2020-06-09 16:57 (587 d 11:11 ago) – Posting: # 21520
Views: 912

Hi Libaiyi,

» I had PK data from US. And now this drug needs to be put into other regions such as Asia. So we setup a new study, it is a single arm trial. How can I compare the PK data from the new trial to historical US PK data?

Never came across such a design.
Most agencies require a local reference product. Then you end up with a new comparative study. The US study is not relevant.
In the rare case where an agency accepts a foreign reference product (in your case the RLD), you could submit the US study.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,829 posts in 4,566 threads, 1,555 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Tuesday 03:08 CET (Europe/Vienna)

The generation of random numbers is too important
to be left to chance.    Robert R. Coveyou

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5